Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation

BACKGROUND: There are no proven effective treatments that can reduce the mortality in heart failure with preserved ejection fraction (HFpEF), probably due to its heterogeneous nature which will weaken the effect of therapy in clinical studies. We evaluated the effect of beta-blocker treatment in HFp...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cardiol Res Pract
Autori principali: Yang, Yanhua, Guo, Suxia, Huang, Ziyao, Deng, Chunhua, Chen, Lihua, Zhou, Guoxiang, Jian, Zhengwei, He, Ruping, Huang, Zhichao, Yao, Yongzhao, Lu, Jiongbin, Hua, Zhiwen, Huang, Yuli
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243006/
https://ncbi.nlm.nih.gov/pubmed/32454997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3059864
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi